Kiyoshi Sato

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 244 citations · Full text

Medicine, Oncology, Pharmacology +7

Preliminary trial of specific targeting therapy against malignant glioma

Taizo Nitta, Hideo Yagita∥, Ko Okumura et al. · The Lancet · 1990 · 238 citations

Medicine, Oncology, Pharmacology +14

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

M. Ikeda, Satoshi Shimizu, Tosiya Sato et al. · Annals of Oncology · 2016 · 170 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Human Glioma-derived Interleukin-10 Inhibits Antitumor Immune Responses In Vitro

Makoto Hishii, Taizo Nitta, Hiroshi Ishida et al. · Neurosurgery · 1995 · 160 citations

Life Sciences, Immunology, Oncology +17

Cytotoxic effects of γδ T cells expanded <i>ex vivo</i> by a third generation bisphosphonate for cancer immunotherapy

Kiyoshi Sato, Shinya Kimura, Hidekazu Segawa et al. · International Journal of Cancer · 2005 · 142 citations

Medicine, Oncology, Pharmacology +17